Cohn JN - Search Results

1

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.

Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F 3rd, DeMets DL, White BG. Cohn JN, et al. N Engl J Med. 1998 Dec 17;339(25):1810-6. doi: 10.1056/NEJM199812173392503. N Engl J Med. 1998. PMID: 9854116 Free article. Clinical Trial.

2

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. Cohn JN, et al. N Engl J Med. 2001 Dec 6;345(23):1667-75. doi: 10.1056/NEJMoa010713. N Engl J Med. 2001. PMID: 11759645 Free article. Clinical Trial.

3

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Taylor AL, et al. Among authors: cohn jn. N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8. N Engl J Med. 2004. PMID: 15533851 Free article. Clinical Trial.

4

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al. Cohn JN, et al. N Engl J Med. 1991 Aug 1;325(5):303-10. doi: 10.1056/NEJM199108013250502. N Engl J Med. 1991. PMID: 2057035 Free article. Clinical Trial.

5

The management of chronic heart failure.

Cohn JN. Cohn JN. N Engl J Med. 1996 Aug 15;335(7):490-8. doi: 10.1056/NEJM199608153350707. N Engl J Med. 1996. PMID: 8672155 Review. No abstract available.

6

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN; Val-HeFT Investigators (Valsartan Heart Failure Trial). Maggioni AP, et al. Among authors: cohn jn. J Am Coll Cardiol. 2002 Oct 16;40(8):1414-21. doi: 10.1016/s0735-1097(02)02304-5. J Am Coll Cardiol. 2002. PMID: 12392830 Free article.

7

Overview of the treatment of heart failure.

Cohn JN. Cohn JN. Am J Cardiol. 1997 Dec 4;80(11A):2L-6L. doi: 10.1016/s0002-9149(97)00843-6. Am J Cardiol. 1997. PMID: 9412537 Review.

8

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.

Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, Ruschitzka F, Lüscher TF; EARTH investigators. Anand I, et al. Among authors: cohn jn. Lancet. 2004 Jul 24-30;364(9431):347-54. doi: 10.1016/S0140-6736(04)16723-8. Lancet. 2004. PMID: 15276394 Clinical Trial.

9

Preventing congestive heart failure.

Cohn JN. Cohn JN. Am Fam Physician. 1998 Apr 15;57(8):1901-4. Am Fam Physician. 1998. PMID: 9575327 Free article. Review.

10

Prevention of heart failure.

Cohn JN. Cohn JN. Cardiology. 1999;92 Suppl 1:22-5; discussion 26-8. doi: 10.1159/000047291. Cardiology. 1999. PMID: 10652968 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters